Biolase, Inc. (BIOLQ) vs Strata Skin Sciences, Inc. (SSKN)
Biolase, Inc. and Strata Skin Sciences, Inc. are both Medical Devices companies. Biolase, Inc. is the larger, with a market value of $2.3M against $1.0M — 2.3× the size. Biolase, Inc. grew revenue faster over the last twelve months: −7.44% against −8.54%. Strata Skin Sciences, Inc. has the higher net margin (−20.4% vs −71.8%) and the higher return on invested capital (−28.4% vs −109.5%). Across the 16 metrics below, Biolase, Inc. leads on 8 and Strata Skin Sciences, Inc. on 8.
Valuation
Profitability
| Metric | BIOLQ | SSKN | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 58.25% | 56.01% |
| Operating margin | (29.37%) | (15.31%) | (15.03%) |
| Net margin | (71.75%) | (20.40%) | (20.40%) |
| Free cash flow margin | (28.55%) | (13.88%) | (7.24%) |
| Return on equity | 1,349.30% | (158.91%) | (15.32%) |
| Return on assets | (100.09%) | (19.13%) | (19.72%) |
| Return on invested capital | (109.48%) | (28.40%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack